Autoimmune polyglandular syndrome type 4: experience from a single reference center.
autoimmune diseases
autoimmune polyglandular syndrome
autoimmunity
polyendocrinopathies
type I diabetes mellitus
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
08
06
2023
accepted:
11
10
2023
medline:
9
11
2023
pubmed:
8
11
2023
entrez:
8
11
2023
Statut:
epublish
Résumé
To characterize patients with APS type 4 among those affected by APS diagnosed and monitored at our local Reference Center for Autoimmune Polyglandular Syndromes. Monocentric observational retrospective study enrolling patients affected by APS diagnosed and monitored in a Reference Center. Clinical records were retrieved and analyzed. 111 subjects (51 males) were affected by APS type 4, mean age at the onset was 23.1 ± 15.1 years. In 15 patients the diagnosis of APS was performed during the first clinical evaluation, in the other 96 after a latency of 11 years (range 1-46). The most frequent diseases were type I diabetes mellitus and celiac disease, equally distributed among sexes. The prevalence of APS type 4 is 9:100,000 people. Type I diabetes mellitus was the leading indicator of APS type 4 in 78% subjects and in 9% permitted the diagnosis occurring as second manifestation of the syndrome. Our data, showing that 50% of patients developed APS type 4 within the first ten years, don't suggest any particular follow-up time and, more importantly, don't specify any particular disease. It is important to emphasize that 5% of women developed premature ovarian failure.
Identifiants
pubmed: 37937054
doi: 10.3389/fendo.2023.1236878
pmc: PMC10627240
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1236878Informations de copyright
Copyright © 2023 Gatta, Anelli, Cimino, Di Lodovico, Piovani, Zammarchi, Gozzoli, Maltese, Cavadini, Agosti, Delbarba, Pirola, Girelli, Buoso, Bambini, Alfieri, Bremi, Facondo, Lupo, Bezzi, Fredi, Mazzola, Gandossi, Saullo, Marini, Licini, Pezzaioli, Pini, Franceschini, Ricci and Cappelli.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
N Engl J Med. 2004 May 13;350(20):2068-79
pubmed: 15141045
J Intern Med. 2009 May;265(5):514-29
pubmed: 19382991
World J Diabetes. 2015 Jun 10;6(5):707-14
pubmed: 26069719
J Pediatr Gastroenterol Nutr. 2003 Jul;37(1):67-71
pubmed: 12827008
Climacteric. 2023 Apr;26(2):95-102
pubmed: 36519275
N Engl J Med. 2018 Mar 22;378(12):1132-1141
pubmed: 29562162
Tissue Antigens. 2011 Apr;77(4):317-24
pubmed: 21388354
Rheumatol Int. 2008 Jul;28(9):919-23
pubmed: 18320193
Arch Gynecol Obstet. 2009 Aug;280(2):177-81
pubmed: 19104824
Diabetologia. 1999 Dec;42(12):1440-1
pubmed: 10651264
Neth J Med. 2009 Dec;67(11):376-87
pubmed: 20009114
Am J Gastroenterol. 1997 Dec;92(12):2210-2
pubmed: 9399754
Acta Biomed. 2003 Apr;74(1):9-33
pubmed: 12817789
Arch Clin Cases. 2021 Oct 27;6(4):109-111
pubmed: 34754918
Pediatrics. 2017 Nov;140(5):
pubmed: 29018046
JAMA. 2021 Aug 24;326(8):717-727
pubmed: 34427600
J Clin Endocrinol Metab. 2009 Jul;94(7):2277-83
pubmed: 19401379
Gastroenterology. 2006 Dec;131(6):1981-2002
pubmed: 17087937
Diabet Med. 1996 May;13(5):464-70
pubmed: 8737029
Endocrine. 2021 Oct;74(1):72-79
pubmed: 33966174
J Pediatr Endocrinol Metab. 2001;14 Suppl 1:597-605
pubmed: 11393550
Autoimmunity. 2016 Jun;49(4):240-7
pubmed: 27138053
N Engl J Med. 2017 Apr 13;376(15):1419-1429
pubmed: 28402773
J Clin Endocrinol Metab. 2002 Feb;87(2):618-23
pubmed: 11836294
Fertil Steril. 2005 Jun;83(6):1734-41
pubmed: 15950644
Pediatr Ann. 1980 Apr;9(4):154-62
pubmed: 6990358
World J Diabetes. 2015 Feb 15;6(1):67-79
pubmed: 25685279
Diabetes Metab Res Rev. 1999 Sep-Oct;15(5):323-7
pubmed: 10585617
J Bone Miner Res. 1994 Mar;9(3):311-5
pubmed: 8191923
J Clin Endocrinol Metab. 2018 May 1;103(5):1977-1984
pubmed: 29409002
J Clin Endocrinol Metab. 1995 Jul;80(7):2112-7
pubmed: 7608264
Clin Gastroenterol Hepatol. 2019 Sep;17(10):1954-1968.e13
pubmed: 30448593
J Pharmacol Pharmacother. 2013 Apr;4(2):168-9
pubmed: 23761721
Horm Res. 1999;52(3):119-24
pubmed: 10725775
Best Pract Res Clin Endocrinol Metab. 2019 Dec;33(6):101344
pubmed: 31606344
Menopause. 2006 Mar-Apr;13(2):265-79
pubmed: 16645540
Am J Physiol. 1999 Apr;276(4):G951-7
pubmed: 10198339
J Autoimmun. 2002 May;18(3):251-7
pubmed: 12126638
Front Immunol. 2022 Oct 27;13:1026416
pubmed: 36389771
J Endocrinol Invest. 2018 Jan;41(1):91-98
pubmed: 28819917
Front Endocrinol (Lausanne). 2021 Jun 16;12:694325
pubmed: 34220719
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4769-4782
pubmed: 31127843
N Engl J Med. 2001 Aug 2;345(5):340-50
pubmed: 11484692
J Endocrinol Invest. 2023 Apr;46(4):643-665
pubmed: 36609775
Autoimmun Rev. 2022 Sep;21(9):103143
pubmed: 35840037
Diabetes. 2008 Apr;57(4):1084-92
pubmed: 18252895